Broadcom Inc. (AVGO) vs PFIZER INC(PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | AVGO | PFE |
|---|---|---|
| Sector | Information Technology | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $63.89B | $62.58B |
| Revenue growth (YoY) | ▲ 23.9% | ▼ 1.6% |
| Net income | $23.13B | $7.81B |
| Gross margin | 67.8% | — |
| Diluted EPS | $4.77 | $1.36 |
| Insider net (6 mo) | −2.1M sh · 23 sells · 1 buys | +130.5K sh · 2 sells · 3 buys |
| Institutional owners | 57 | 44 |
| Institutional value held | $1.00T | $61.93B |
| Next earnings (est.) | Sep 3, 2026 | Nov 3, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About Broadcom Inc. (AVGO)
Broadcom Inc., a Delaware corporation with over 60 years of history rooted in AT&T/Bell Labs, Lucent, and Hewlett-Packard, is a global technology leader in semiconductor and infrastructure software solutions, shaped by acquisitions including LSI, Broadcom Corp
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across b
Source: SEC EDGAR.